首页> 外文期刊>Veterinary Ophthalmology >A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1
【24h】

A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1

机译:具有抗1型猫疱疹病毒活性的抗病毒药物和其他化合物的综述

获取原文
获取原文并翻译 | 示例
           

摘要

Feline herpesvirus type 1 (FHV-1) is a common and important cause of ocular surface disease, dermatitis, respiratory disease, and potentially intraocular disease in cats. Many antiviral drugs developed for the treatment of humans infected with herpesviruses have been used to treat cats infected with FHV-1. Translational use of drugs in this manner ideally requires methodical investigation of their in vitro efficacy against FHV-1 followed by pharmacokinetic and safety trials in normal cats. Subsequently, placebo-controlled efficacy studies in experimentally inoculated animals should be performed followed, finally, by carefully designed and monitored clinical trials in client-owned animals. This review is intended to provide a concise overview of the available literature regarding the efficacy of antiviral drugs and other compounds with proven or putative activity against FHV-1, as well as a discussion of their safety in cats.
机译:1型猫疱疹病毒(FHV-1)是猫眼表疾病,皮炎,呼吸系统疾病和潜在眼内疾病的常见且重要原因。为治疗感染疱疹病毒的人类而开发的许多抗病毒药物已用于治疗感染FHV-1的猫。理想情况下,以这种方式进行药物的转化使用需要系统地研究其抗FHV-1的体外功效,然后在正常猫中进行药代动力学和安全性试验。随后,应在实验接种动物中进行安慰剂对照功效研究,最后,对客户拥有的动物进行精心设计和监测的临床试验。这篇综述旨在提供有关抗病毒药物和其他对FHV-1的已证明或推定活性的化合物的功效的现有文献的简要概述,并讨论它们在猫中的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号